Vaccines

[키워드] 2019 novel coronavirus 2019-nCoV ACE2 ACE2 receptor ACE2-expressing cells acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 angiotensin angiotensin-converting enzyme 2 antibodies binding binding affinity causative agent characterization coronavirus coronavirus disease Coronavirus disease 2019 CoV CoV infection COVID-19 cross-neutralization cross-neutralize SARS-CoV-2 cross-react develop effective Entry inhibitor entry inhibitors enzyme exhibited fusion global public health host cells Human Immunotherapy in viral Infection inhibiting Novel coronavirus outbreak Protein RBD RBD protein Receptor-binding domain receptors respiratory S protein Safe SARS-CoV infection SARS-CoV RBD SARS-CoV RBD-based vaccine SARS-CoV RBD-based vaccines SARS-CoV RBD-induced antisera SARS-CoV RBD-specific antibodies SARS-CoV RBD-specific antibody SARS-CoV-2 SARS-CoV-2 and SARS-CoV infection SARS-CoV-2 RBD SARS-CoV-2 RBD protein SARS-CoV-2 S protein severe acute respiratory syndrome Coronavirus significantly higher specific antibodies Spike protein target the RBD protein the receptor-binding domain Therapeutics Vaccine Vaccines Viral viral attachment inhibitor viral infection viral inhibitor
[DOI] 10.1038/s41423-020-0400-4 PMC 바로가기 [Article Type] Article